DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  European Journal of Cancer

• Publication date

  1996-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0959-8049(96)00016-0PMID 8758254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization.

  1994cited by this paper
• Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung.

  1994cited by this paper
• Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe

  1993cited by this paper
• Evidence of gene amplification in the form of double minute chromosomes is frequently observed in lung cancer.

  1993cited by this paper
• Co‐amplification of the gene for parathyroid hormone‐related protein (PTHRP) and KRAS2 in a human lung cancer cell line

  1993cited by this paper
• Amplification of the topoisomerase ii α gene in a non‐small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase ii α and β loci in normal tissue

  1992cited by this paper
• Amplification of the topoisomerase II alpha gene in a non-small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase II alpha and beta loci in normal tissue.

  1992cited by this paper
• Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung.

  1992cited by this paper
• Chromosome abnormalities in human non-small cell lung cancer.

  1992cited by this paper
• Three distinct regions involved in 3p deletion in human lung cancer.

  1992cited by this paper
• Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer

  1990cited by this paper
• Chromosome alterations in 21 non‐small cell lung carcinomas

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries

  1988cited by this paper
• Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.

  1988cited by this paper
• Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4.

  1988cited by this paper
• Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer

  1987cited by this paper
• Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung.

  1987cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.

  1987cited by this paper
• Oncogene amplification in tumor cells.

  1986cited by this paper
• Amplification and enhanced expression of cellular oncogene c-Ki-ras-2 in a human epidermoid carcinoma of the lung.

  1985cited by this paper
• Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

  1985cited by this paper
• DNA sequence amplification in mammalian cells.

  1984cited by this paper
• Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).

  1982cited by this paper
• MICROTECHNIQUE FOR CULTURING LEUKOCYTES FROM WHOLE BLOOD.

  1963cited by this paper

• The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

  2019cites this paper
• Cytoplasmic expression of epithelial cell transforming sequence 2 in lung adenocarcinoma and its implications for malignant progression

  2018cites this paper
• Telomere Maintenance Mechanisms in Cancer

  2018cites this paper
• SOX2 in cancer stemness: tumor malignancy and therapeutic potentials

  2018cites this paper
• 3q26‐29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes

  2017influential citation
• The chromosome 3q26 OncCassette: A multigenic driver of human cancer.

  2016cites this paper
• Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.

  2015cites this paper
• The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.

  2014cites this paper
• p31comet inactivates the chemically induced Mad2-dependent spindle assembly checkpoint and leads to resistance to anti-mitotic drugs

  2013cites this paper
• Eukaryotic translation initiation factors in cancer development and progression.

  2013cites this paper
• True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs

  2012cites this paper
• Protein kinase Cι expression and oncogenic signaling mechanisms in cancer

  2011cites this paper
• Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments.

  2011cites this paper
• The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer.

  2010cites this paper
• Crosstalk between Insulin and Wnt Signaling Pathways

  2010cites this paper
• Ect2 links the PKCι-Par6α Complex to Rac1 Activation and Cellular Transformation

  2009influential citation
• Molekulare Signaturen im Blut von Patienten mit Bronchialkarzinomen

  2009cites this paper
• Protein kinase C isozymes as therapeutic targets for treatment of human cancers.

  2008cites this paper
• INHIBITION OF PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) SIGNALLING LEADS TO RESISTANCE TO CHEMOTHERAPEUTIC AGENTS IN HUMAN CANCER CELLS

  2008cites this paper
• 3q26AmplificationandPolysomyofChromosome3 inSquamousCell Lesions of the Lung: AFluorescence In situHybridization Study

  2007cites this paper
• 3q26 Amplification and Polysomy of Chromosome 3 in Squamous Cell Lesions of the Lung: A Fluorescence In situ Hybridization Study

  2007cites this paper
• Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26‐27 in squamous cell carcinoma of the lung

  2007cites this paper
• Evi1 is a survival factor which conveys resistance to both TGFβ- and taxol-mediated cell death via PI3K/AKT

  2006cites this paper
• Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer.

  2006cites this paper
• Chromosomal aberrations in Korean nonsmall cell lung carcinomas: degenerate oligonucleotide primed polymerase chain reaction comparative genomic hybridization studies.

  2004cites this paper
• Reverse painting highlights the origin of chromosome aberrations

  2004cites this paper
• TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.

  2003cites this paper
• Chromosomal imbalances in human lung cancer

  2002cites this paper
• Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions.

  2001cites this paper
• Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer

  2001cites this paper
• Translation initiation factor eIF‐4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma

  2001cites this paper
• Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas

  2001cites this paper
• Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.

  2001cites this paper
• [Improved prognostic assessment of head-neck carcinomas by new genetic markers].

  2000cites this paper
• Molekularzytogenetische Charakterisierung von Plattenepithelkarzinomen des Kopf-Hals-Bereiches

  2000cites this paper
• Gene amplification at chromosome 1pter-p33 including the genes PAX7 and ENO1 in squamous cell lung carcinoma.

  2000cites this paper
• Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung.

  2000cites this paper
• Verbesserte Prognoseeinschätzung bei Kopf-Hals-Karzinomen durch neue genetische Marker

  2000cites this paper
• A broad amplification pattern at 3q in squamous cell lung cancer--a fluorescence in situ hybridization study.

  2000cites this paper
• Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization.

  2000cites this paper
• Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma.

  1999cites this paper
• Role of amplified genes in the production of autoantibodies.

  1999cites this paper
• Chromosome 3 imbalances are the most frequent aberration found in non-small cell lung carcinoma.

  1999cites this paper
• Short communication Chromosome 3 imbalances are the most frequent aberration found in non-small cell lung carcinoma

  1999cites this paper
• DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

  1998cites this paper
• DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma

  1998cites this paper
• Clinical relevance of genetic alterations in lung cancer

  1998cites this paper
• Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung.

  1997cites this paper
• Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma.

  1997cites this paper
• Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas.

  1997cites this paper
• Differential elimination of 3p and retention of 3q segments in human/mouse microcell hybrids during tumor growth

  1997cites this paper